HB Wealth Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

HB Wealth Management’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$54.8K	Buy	+13,806	New	+$57.6K	﹤0.01%	1835

Other funds holding IRWD

CWA Asset Management Group Naples, Florida $3.39B AUM 25.16% 1-Year Est. Return

Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

Range Financial Group Tigard, Oregon $361M AUM 58.71% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Kathmere Capital Management Wayne, Pennsylvania $2.07B AUM 20.3% 1-Year Est. Return

Krilogy Financial St. Louis, Missouri $3.66B AUM 22.28% 1-Year Est. Return

Magnus Financial Group New York $1.5B AUM 16.47% 1-Year Est. Return

HB Wealth Management's IRWD Position: Q3 2026 in Review

HB Wealth Management opened a new position in Ironwood Pharmaceuticals (IRWD) in Q3 2026: 13,806 shares worth $54.8K. The stake represents ﹤0.01% of the portfolio and ranks #1835 among its holdings.

30 funds tracked by Wall St. Rank hold IRWD as of Q3 2026.

HB Wealth Management held 13,806 shares of Ironwood Pharmaceuticals worth $54.8K as of Q3 2026.
Ironwood Pharmaceuticals was a new HB Wealth Management position in Q3 2026.
Ironwood Pharmaceuticals made up ﹤0.01% of HB Wealth Management's portfolio in Q3 2026, its #1835 holding.
30 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2026.

Based on HB Wealth Management's 13F filing for Q3 2026, filed 23 Oct 2026.